Aptevo Therapeutics Earlier Reported Q3 EPS $(0.16) Up From $(0.55) YoY, Sales $9M Up From $5.8M YoY

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(0.16) per share. This is a 70.91 percent increase over losses of $(0.55) per share from the same period last year. The company reported $9 million in

Benzinga · 11/07/2019 14:56

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(0.16) per share. This is a 70.91 percent increase over losses of $(0.55) per share from the same period last year. The company reported $9 million in sales this quarter. This is a 55.17 percent increase over sales of $5.8 million the same period last year.